The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review

FHIT is a bona fide tumor-suppressor gene and its loss contributes to tumorigenesis of epithelial cancers including breast cancer (BC). However, the association and clinicopathological significance between FHIT promoter hypermethylation and BC remains unclear. The purpose of this study is to conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yunshu, Wang, Xiaoli, Li, Jun, Xu, Junming, Xu, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598219/
https://www.ncbi.nlm.nih.gov/pubmed/26491255
http://dx.doi.org/10.2147/DDDT.S89861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598219/
https://www.ncbi.nlm.nih.gov/pubmed/26491255
http://dx.doi.org/10.2147/DDDT.S89861

Ejemplares similares